1. Home
  2. POWI vs ACAD Comparison

POWI vs ACAD Comparison

Compare POWI & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWI
  • ACAD
  • Stock Information
  • Founded
  • POWI 1988
  • ACAD 1993
  • Country
  • POWI United States
  • ACAD United States
  • Employees
  • POWI N/A
  • ACAD N/A
  • Industry
  • POWI Semiconductors
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • POWI Technology
  • ACAD Health Care
  • Exchange
  • POWI Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • POWI 3.3B
  • ACAD 2.8B
  • IPO Year
  • POWI 1997
  • ACAD 2004
  • Fundamental
  • Price
  • POWI $51.24
  • ACAD $16.32
  • Analyst Decision
  • POWI Buy
  • ACAD Buy
  • Analyst Count
  • POWI 6
  • ACAD 17
  • Target Price
  • POWI $78.00
  • ACAD $24.00
  • AVG Volume (30 Days)
  • POWI 530.6K
  • ACAD 1.5M
  • Earning Date
  • POWI 05-06-2025
  • ACAD 05-07-2025
  • Dividend Yield
  • POWI 1.67%
  • ACAD N/A
  • EPS Growth
  • POWI N/A
  • ACAD N/A
  • EPS
  • POWI 0.56
  • ACAD 1.36
  • Revenue
  • POWI $418,973,000.00
  • ACAD $957,797,000.00
  • Revenue This Year
  • POWI $15.74
  • ACAD $13.07
  • Revenue Next Year
  • POWI $17.08
  • ACAD $9.97
  • P/E Ratio
  • POWI $89.71
  • ACAD $12.28
  • Revenue Growth
  • POWI N/A
  • ACAD 31.85
  • 52 Week Low
  • POWI $49.05
  • ACAD $14.15
  • 52 Week High
  • POWI $79.13
  • ACAD $20.68
  • Technical
  • Relative Strength Index (RSI)
  • POWI 33.23
  • ACAD 34.18
  • Support Level
  • POWI $54.04
  • ACAD $16.86
  • Resistance Level
  • POWI $57.22
  • ACAD $17.31
  • Average True Range (ATR)
  • POWI 1.86
  • ACAD 0.51
  • MACD
  • POWI -0.53
  • ACAD -0.03
  • Stochastic Oscillator
  • POWI 24.29
  • ACAD 10.97

About POWI Power Integrations Inc.

Power Integrations Inc design, develop and market analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, and home-automation, or internet of things applications such as networked thermostats, power strips and security devices.. Geographically, the company generates maximum revenue from China and Hong Kong.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: